From: Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients
 | Recurrence | DFS | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate Analysis | Multivariate Analysis | Univariate Analysis | Multivariate Analysis | |||||||||
HR | 95% CI | p value | HR | 95% CI | p value | HR | 95% CI | p value | HR | 95% CI | p value | |
NLR | ||||||||||||
  ≤ 4.7 | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
  > 4.7 | 1.67 | 0.64–4.36 | 0.293 | 1.1 | 0.38–3.21 | 0.862 | 2.03 | 1.16–3.57 | 0.014 | 1.88 | 1.01–3.52 | 0.048 |
Gender | ||||||||||||
 Female | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 Male | 1.81 | 0.81–4.04 | 0.15 | 1.73 | 0.76–3.93 | 0.189 | 1.36 | 0.84–2.18 | 0.207 | 1.41 | 0.87–2.30 | 0.163 |
Age | ||||||||||||
  ≤ 72 | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
  > 72 | 0.9 | 0.44–1.83 | 0.763 | 1.02 | 0.48–2.17 | 0.949 | 1.70 | 1.08–2.65 | 0.021 | 1.83 | 1.15–2.91 | 0.011 |
Primary tumor | ||||||||||||
 Right colon | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 Left colon | 0.84 | 0.29–2.46 | 0.753 | 0.7 | 0.23–2.14 | 0.535 | 0.81 | 0.41–1.61 | 0.543 | 0.71 | 0.35–1.46 | 0.354 |
 Rectum | 1.34 | 0.61–2.96 | 0.463 | 1.53 | 0.66–3.55 | 0.316 | 1.39 | 0.85–2.28 | 0.196 | 1.46 | 0.85–2.51 | 0.175 |
Grade | ||||||||||||
 Low | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 Medium + High | 1.43 | 0.55–3.73 | 0.464 | 1.98 | 0.73–5.35 | 0.177 | 1.14 | 0.65–2.00 | 0.646 | 1.18 | 0.66–2.14 | 0.574 |
T | ||||||||||||
 T1 | 1 |  |  |  |  |  | 1 |  |  |  |  |  |
 T2 | 8.74E + 08 | 8.74e + 08–8.74e + 08 | . |  |  |  | 2.96 | 0.38–22.96 | 0.299 |  |  |  |
 T3 | 1.68e + 09 | 5.79e + 08–4.88e + 09 | 0 |  |  |  | 5.2 | 0.72–37.60 | 0.102 |  |  |  |
 T4 | 3.33e + 09 | 8.89e + 08–1.25e + 10 | 0 |  |  |  | 8.95 | 1.16–69.40 | 0.036 |  |  |  |
N | ||||||||||||
 N0 | 1 |  |  |  |  |  | 1 |  |  |  |  |  |
 N1 | 1.06 | 0.43–2.57 | 0.906 |  |  |  | 1.04 | 0.61–1.79 | 0.884 |  |  |  |
 N2 | 3.60 | 1.54–8.46 | 0.003 |  |  |  | 2.88 | 1.64–5.07 | < 0.001 |  |  |  |
No lymph nodes yield | ||||||||||||
  ≥ 12 | 1 |  |  |  |  |  | 1 |  |  | 1 |  |  |
  < 12 | 0.55 | 0.13–2.29 | 0.408 | 0.55 | 0.13–2.44 | 0.433 | 1.56 | 0.86–2.83 | 0.145 | 1.7 | 0.89–3.24 | 0.106 |
Stage | ||||||||||||
 Stage I | 1 |  |  |  |  |  | 1 |  |  | 1 |  |  |
 Stage II | 3.86 | 0.88–16.99 | 0.074 | 5.14 | 1.14–23.30 | 0.034 | 2.35 | 1.09–5.07 | 0.029 | 2.80 | 1.28–6.10 | 0.01 |
 Stage III | 4.81 | 1.10–21.05 | 0.037 | 5.22 | 1.13–24.13 | 0.035 | 2.80 | 1.30–6.03 | 0.008 | 3.06 | 1.38–6.78 | 0.006 |
Perineural invasion | ||||||||||||
 No | 1 |  |  |  |  |  | 1 |  |  | 1 |  |  |
 Yes | 2.03 | 0.71–5.84 | 0.189 | 0.89 | 0.26–3.05 | 0.848 | 1.37 | 0.63–2.99 | 0.428 | 0.54 | 0.22–1.32 | 0.176 |
Vascular invasion | ||||||||||||
 No | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 Yes | 4.05 | 1.93–8.49 | 0 | 4.23 | 1.78–10.03 | 0.001 | 2.36 | 1.39–4.02 | 0.001 | 2.38 | 1.26–4.49 | 0.007 |
Lymphatic invasion | ||||||||||||
 No | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 Yes | 2.42 | 1.04–5.64 | 0.04 | 1.16 | 0.43–3.11 | 0.769 | 2.07 | 1.20–3.59 | 0.009 | 1.48 | 0.77–2.83 | 0.237 |